Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital
Term to run through May 2023Available capital under the new purchase agreement is $40 MillionGARDEN CITY, N.Y., May 15, 2020 […]
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
– Study Showed High Variability in Levels of CSF Biomarkers Over 28 Days –– Drug Was Safe and Well-tolerated –AUSTIN, […]
Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer
REDWOOD CITY, Calif., May 15, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical […]
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
Norwood, MA, May 15, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage […]
Biometric Security Solutions Provider BIO-key Reports Fiscal Year 2019 and Preliminary Q1 2020 Results; Hosts Investor Webcast Today at 10am ET
WALL, N.J., May 15, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric software and […]
Sequential Brands Group Announces First Quarter 2020 Results
NEW YORK, May 15, 2020 (GLOBE NEWSWIRE) — Sequential Brands Group, Inc. (“Sequential” or the “Company”) (Nasdaq:SQBG) today announced financial […]
Integra LifeSciences Announces Positive Clinical Results for Integra® Bilayer Wound Matrix (IBWM)
PRINCETON, N.J., May 15, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, […]
Ultragenyx Announces Positive Data from Confirmatory Cohort of Phase 1/2 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
All Patients in Cohort 3 Demonstrate Increased Time to Hypoglycemia and a Substantial Reduction in Cornstarch UseIntroduction of Continuous Glucose […]
Mersana Therapeutics to Present Two Posters at the American Association for Cancer Research 2020 Virtual Annual Meeting
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
BioCardia Reports First Quarter 2020 Financial Results and Business Highlights
SAN CARLOS, Calif., May 15, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions […]
